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The forkhead transcription factor gene FOXC1 (formerly FKHL7) is responsible for a number of glaucoma phe-
notypes in families in which the disease maps to 6p25, although mutations have not been found in all families in
which the disease maps to this region. In a large pedigree with iris hypoplasia and glaucoma mapping to 6p25
(peak LOD score 6.20 [recombination fraction 0] at D6S967), no FOXC1 mutations were detected by direct
sequencing. However, genotyping with microsatellite repeat markers suggested the presence of a chromosomal
duplication that segregated with the disease phenotype. The duplication was confirmed in affected individuals by
FISH with markers encompassing FOXC1.These results provide evidence of gene duplication causing developmental
disease in humans, with increased gene dosage of either FOXC1 or other, as yet unknown genes within the duplicated
segment being the probable mechanism responsible for the phenotype.
Introduction
The glaucomas are a heterogeneous group of disorders
that are characterized by an optic neuropathy in which
retinal ganglion cell death leads to excavation of the
optic-nerve head and to visual field loss. They are re-
sponsible for 16 million cases of blindness and represent
the second most common cause of visual loss worldwide
(Quigley 1996). On the basis of population surveys, it
is estimated that20% of glaucoma cases have a genetic
basis (Wolfs et al. 1998), although evidence suggests that
this is a conservative figure (Alward et al. 2000; Mackey
et al. 2000). The genetic heterogeneity of the inherited
glaucomas is illustrated by the number of mapped loci
and the number of glaucoma-causing genes (PITX2
[MIM 601542], MYOC [MIM 601652], CYP1B1
[MIM 601771], LMX1B [MIM 602575], and FOXC1
[MIM 601090]) that have been identified so far (Craig
et al. 1999).
Mutations in the forkhead transcription factor gene
FOXC1 cause a range of developmental anomalies as-
sociated with glaucoma, including Axenfeld anomaly,
Rieger anomaly, iris hypoplasia, and Rieger syndrome
(Nishimura et al. 1998; Mirzayans et al. 2000). These
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phenotypes have been reported both in isolated cases
and in pedigrees in which an autosomal dominant pat-
tern of inheritance is observed. However, four such ped-
igrees that map to 6p25 do not contain a mutation in
the coding region of the FOXC1 gene (Jordan et al.
1997; Morissette et al. 1997; Mears et al. 1998). In two
of these families, FOXC1 has been excluded from the
disease-causing interval, by mapping data based on re-
combination events. These findings suggest the existence
of a second glaucoma-causing gene on 6p25 (Mears et
al. 1998). In this article, we report the mapping of a
large, previously unreported pedigree with iris hypo-
plasia and glaucoma, in which a chromosomal dupli-
cation event involving FOXC1 appears to be respon-
sible for the phenotype.
Subjects and Methods
Family and Clinical Data
The family presented has an autosomal dominantly
transmitted form of iris hypoplasia and glaucoma that
can be traced back six generations. The family includes
21 living affected individuals, of whom 18 were ascer-
tained, together with 9 unaffected siblings and 9 spouses
(fig. 1a). The study had the approval of the Moorfields
Eye Hospital ethics committee, and informed consent
was obtained from all participants.
Clinical examination (performed by O.J.L. and T.J.)
included portable slit-lamp biomicroscopy, gonioscopy,
disk examination, and anterior-segment photography.
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Figure 1 a, Abridged pedigree drawing illustrating the affected (1–18) and the unaffected (19–31) individuals analyzed. b, Photograph of
ethidium-bromide–stained gel, showing D6S967 PCR products. Each lane number corresponds with that of the individual in the pedigree in a.
All affected family members had marked hypoplasia of
the iris stroma, which had been apparent since birth,
and a prominent sphincter pupillae (fig. 2A and C). An
anomalous angle configuration with an anterior iris in-
sertion and/or an increased number of iris strands was
present in the majority of individuals, although this
could not be accurately assessed in individuals who had
undergone goniotomy during infancy. The clinical find-
ing of iris hypoplasia was the criterion used to assign
an individual’s affected status. Patients’ ophthalmic re-
cords were obtained and used to confirm the ophthalmic
history. Glaucoma (diagnosed by the combination of op-
tic-disk cupping and visual field loss) was present in all
18 affected individuals who could be fully examined,
and the age at onset was generally during the 1st decade
of life (range 0–18 years). The clinical finding of iris
atrophy was confirmed by histological examination of
a peripheral iridectomy specimen collected from indi-
vidual 1 during glaucoma surgery (fig. 2C). No dental
or umbilical abnormalities were present in affected
individuals.
Genotyping and Linkage Analysis
Genomic DNA was extracted, from either venous
blood or buccal mucosa samples, from 32 individuals, by
standard techniques (Qiagen, Nucleon Biosciences). Each
DNA sample was subjected to 35 cycles of PCR ampli-
fication using microsatellite tri-/tetranucleotide-repeat
markers in 20-ml reaction volumes (20 ng genomic DNA,
10 pmol of each primer, 200 mM of each dNTP, 1.5 mM
MgCl, and 2 units of Taq DNA Polymerase [Promega]).
The microsatellite markers (D6S1600, D6S942, D6S967,
D6S344, D6S1713, and D6S1574 [all from Research Ge-
netics]) were amplified by 35 cycles of 94C for 1 min,
55C for 1 min, and 72C for 1 min. The amplified PCR
products were separated by 6% nondenaturing PAGE
(Protogel) and were visualized by staining with ethidium
bromide. Subsequent genotyping was done manually.
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Figure 2 Ocular anterior-segment photographs and iris histology micrographs from members of the pedigree and normal controls. A,
Left eye of individual 3, displaying the characteristic iris stromal atrophy, with exposure of the underlying iris sphincter visible as a pale ring
encircling the pupil. A surgical iridectomy is present. B, Left eye of unaffected individual (individual 20); the semicircular light reflex is a corneal
reflection from the ring flash. C, Micrograph of iris specimen (individual 1), confirming that the reduction in iris thickness to ∼150 mm was
due primarily to a reduction in stromal thickness. At its thinnest, the iris consists of little more than the thickness of the dilator muscle alone,
and elsewhere the thinned stroma contained normal blood vessels and was of normal cellular density. (Separation of the posterior pigment
epithelium from the iris stroma is a surgical artifact). D, Micrograph of normal iris, for comparison (thickness ∼350 mm).
Two-point linkage analysis was performed using the
MLINK component of the LINKAGE program, version
5.1 (Lathrop and Lalouel 1984), with an autosomal
dominant model, 100% penetrance, a gene frequency of
.0001 and a mutation rate of .00001 (table 1). Because
the phenotype is apparent during infancy, no age cor-
rection for penetrance was required.
Mutation Detection
PCR amplification of FOXC1 and FOXF2 gene se-
quences was performed in 20-ml reactions at an annealing
temperature of 60C, by a modification of published
methodology (Mears et al. 1998) in which 10% glycer-
ol and 5% formamide were substituted for DMSO, to
alleviate the problems associated with amplification of
GC-rich sequences. The FOXC1 and FOXF2 primer se-
quences used are shown in table 2 (Mears et al. 1998).
After purification with QIAquick columns (Qiagen), un-
der standard conditions, samples were sequenced bidi-
rectionally with fluorescent dideoxynucleotides (PE Bio-
systems) on an ABI 373 automated sequencer.
FISH
As part of a positional cloning approach, a YAC/PAC
contig spanning FOXC1 was established: YACs 870D6
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Table 1
Two-Point LOD Scores between the Iris Hypoplasia
Locus and Six Markers on 6p25
LOCUS
LOD SCORE AT v p
.00 .05 .10 .20 .30 .40
D6S1600 0 .66 .22 .73 .69 .41
D6S942  3.90 3.68 2.86 1.84 .78
D6S967 6.20 5.65 5.08 3.87 2.56 1.20
D6S344 1.45 1.36 1.23 .87 .50 .20
D6S1713 5.3 4.98 4.50 3.31 2.92 1.44
D6S1574  2.17 2.19 1.78 1.16 .50
Table 2
Sequences of Primer Pairs Used in PCR Amplification of FOXC1 and FOXF2
Gene
Forward Primer
(5′r3′)
Reverse Primer
(5′r3′)
FOXC1 ACCACCCTGCGGCCCACCAAG CGGAGACCTGGGCCACTTGGC
CCCGGACTCGGACTCGGC CCGAGGTAGGGCACCACT
GTCCAGCCCCAACTCCCT GCATGGCGGTGTAGCC
GGCTACACCGCCATGC ACTGGTAGATGCCGTTCAGG
GGCGCTTCAAGAAGAAGGAC CTGAAGCCCTGGCTATGGT
AAGATCGAGAGCCCCGAC CAGAAGGCCGGAGCTGAG
ACCATAGCCAGGGCTTCAG CAGGTTGCAGTGGTAGGTCC
CAAGCCATGAGCCTGTACG GGGTTCGATTTAGTTCGGCT
FOXF2 CTGGGAGGCCGTTGCGCAAGGCAG CGCTCCAGGCCGCCCTGATGAGC
CGCTCCAGGCCGCCCTGATGAGC CTCGGTGCGCCACAATCTCTC
CTCGCCCAGCAAGCGCCTGACG GGCTTCGACTTCCAGGCGCCC
CGGAAGTGCCAGGCGCTCAAG AGCCCGGTACCCTCGTCCCCG
CTGCCCGGTGCCCGCGGGACCCG CTGGCGGCCACTGCCACTCCCAC
CACCCTGCCATCCACTGGATGAC GAGGGGGCAGATAGAAAC
and 905F3 were from the database of the Whitehead
Institute for Biomedical Research/MIT Center for Ge-
nome Research; PACs dJ118B18, dJ181K4, dJ181D15,
dJ183B12, and dJ135A7 were isolated by screening the
RPCI1 library with D6S344. To confirm that PACs con-
tained FOXC1, STS (sequence-tagged site) content map-
ping was performed with FOXC1-specific primers.
Metaphase-chromosome preparations were obtained
from short-term peripheral blood cultures of individuals
13 and 14 and of a normal control, by standard meth-
ods. PAC 135A7 (chromosome 6p25) and PAC 124L22
(chromosome 2q21) (also derived from the RPCI1 li-
brary), labeled, by nick translation, with biotin and di-
goxygenin, respectively, were used as probes for FISH.
The probes were simultaneously hybridized to meta-
phase and interphase nuclei from the three individuals.
The signals were detected using fluorescein isothiocyan-
ate avidin for biotin and rhodamine antidigoxygenin, as
described elsewhere (Fox and Povey 2000). The signals
were analyzed using fluorescent microscopy and were
imaged by cooled CCD (Photometrics) and Smartcap-
ture software (Vysis).
Results
Positive LOD scores were obtained for markers on
chromosome 6p25. The maximum two-point LOD
score of 6.20 (recombination fraction 0) was obtained
with D6S967; recombination events at D6S942 and
D6S1713 define the ∼6-cM disease-gene–containing in-
terval. The markers and two-point LOD scores are
shown in table 1.
Unusual genotyping results were obtained with
marker D6S967, which suggests the presence of a du-
plication event. All affected individuals shared two
D6S967 alleles of consistent size across the pedigree and
displayed an extra allele either as a third band (indi-
viduals 2, 5–10, 12, 15, 17, and 18) or as an allele band
of twice-normal signal intensity (fig. 1b). PCR prod-
ucts from representative alleles were extracted from the
gel and were sequenced bidirectionally to confirm these
findings (data not shown). No other microsatellite
markers exhibited this phenomenon. Direct sequencing
of FOXC1 and FOXF2 demonstrated that nomutations
were present in these genes. FISH was performed to
confirm the duplication event observed with D6S967.
The majority of metaphase preparations from af-
fected individuals contained a hybridization signal on
chromosome 6p25, in which one homologue contained
a brighter signal than its partner (individual 13, 6 of 9;
individual 14, 9 of 11; control individual, 1 of 6). In
contrast, signals of PAC 124L22 (2q21) were mainly of
similar intensity, the number of unequal signals being
as follows: individual 13, 1 of 9; individual 14, 2 of 11;
control individual, 2 of 6. The chromosome morphol-
ogy of the two homologues at 6p25 appeared indistin-
guishable. Examination of 239 interphase-nuclei prep-
arations from both affected individuals (119 from
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Figure 3 Two-color FISH analysis using PAC 135A7 (chromo-
some 6 [green signal]) and PAC 124L22 (chromosome 2 [red signal]).
Montage of metaphase and interphase (bottom right) nuclei prepa-
rations from individual 13 is shown. One chromosome 6 homologue
(arrow) displays a green signal of increased intensity, which, on the
interphase, is shown as a double signal.
Table 3
Analysis of Total Counts of Signals from PAC 135A7
(6p25) and Control PAC 124L22 (2q21) in
Individual 13 and Control
Individual 13
(n p 119)
Control
(np 74)
PAC used 6p25 2q21 6p25 2q21
No. of individuals:
Symmetricala 46 88 51 51
Asymmetricalb 73 31 23 23
a Equal numbers of signals on each homologue (i.e.,
1  1 or 2  2).
b Unequal numbers of signals on each homologue
(i.e., 1  2, 1  a cluster of signals, or 2  a cluster
of signals).
individual 13; 120 from individual 14) demonstrated
that the green signal from PAC 135A7 was frequently
duplicated, with the maximum separation of the two
signals being the diameter of the signal (fig. 3).
The interphase nuclei were analyzed by scoring the
number of distinct signals in each cell, with no attempt
to assess the size of the signal. In no case were three or
more widely separated signals seen. Thus, a score of
three signals was most easily interpreted as two signals
on one homologue and one signal on the other, and a
score of four signals as two on each homologue (indi-
cating a cell in G2). As expected in a culture not com-
pletely synchronized and where objects separated in
three dimensions are viewed in two dimensions, there
is considerable background variation in the number of
signals seen per cell. The examples of three signals in
one cell in the control individual or when the control
probe was used are presumably either the result of fail-
ure to see the second signal on one homologue in a G2
cell (because of orientation within the nucleus) or an
early stage of G2 when the replication is slightly
asynchronous.
In spite of the background variation in the number
of signals seen per cell, statistical analysis of the number
of signals (table 3) gives a very clear result. In patient
13, the proportion of cells containing asymmetrical sig-
nals with the 6p25 probe (61%) is much greater than
either that with the 2q21 probe (26%) ( ;2x p 30 P !1
) or that observed in the control individual (31%).001
( ; ). In the 74 control cells analyzed,2x p 17 P ! .0011
the total number of signals from the two probes were
virtually identical (190 for 6p25; 188 for 2q21), and
equal numbers were asymmetrical. With the control
probe 2q21, there is no difference, in the distribution
of symmetrical and asymmetrical signals, between the
patient and the control ( ; ). (The dif-2x p 0.57 P ! .491
ference of distribution of signals between patient 13 and
the control remains highly significant even if only those
cells containing a symmetric 1:1 signal in 2q21 are con-
sidered [ ; ]; see table 4).2x p 15 P ! .0011
Very similar results were obtained with patient 14,
scored for 120 cells. In this case, 69 (57%) of the 6p25
signals were asymmetrical, compared with 25 (21%) of
the 2q21 signals ( ; ).2x p 34 P ! .0011
Discussion
This article has described a large pedigree with inherited
iris hypoplasia and glaucoma that maps to 6p25 and in
which direct sequencing has failed to demonstrate mu-
tations in the known FOXC1 gene. In four other ped-
igrees with a similar phenotype mapping to 6p25, direct
sequencing of FOXC1 has also not demonstrated mu-
tations (Mears et al. 1998).
On the basis of the anomalous genotyping results
observed with D6S967—in which the 18 affected in-
dividuals inherited three alleles, two of which were
shared in all these individuals—we hypothesize that a
duplication event on 6p25 is present in the affected
members of this pedigree. Since the size of a duplicated
tetranucleotide repeat is not under any evolutionary
pressure to remain conserved, we believe that, after the
duplication event occurred, replication slippage led to
the creation of unequal-length alleles that have enabled
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Table 4
Analysis of 6p25 Probe Only in Those Cells
in Which the 2q21 Probe Had Two Signals
Individual 13 Control
No. symmetrical 30 34
No. asymmetrical 38 7
NOTE.—Data are as defined in the footnotes
to table 3.
this duplication to be observed on a microsatellite gel.
FISH of a PAC clone demonstrating a duplication on
6p25 that includes FOXC1 confirms our interpretation
of the genotyping data. The high number of cytogenetic
abnormalities reported in this region (Davies et al. 1999;
Sheffield et al. 1999) suggests that this location may be
an area of genetic instability. The telomeric location, the
GC-rich content, and the presence of multiple CCG re-
peats (Jones et al. 2000) within and around the FOXC1
gene may also be contributing to the likelihood of such
events. However, since this duplication is present in
three living generations of this pedigree, it is highly
probable that it represents a stable ancestral event.
One hypothesis to explain the genetic basis of iris
hypoplasia in large pedigrees with mapping to 6p25 that
do not contain FOXC1 mutations is the existence of a
second glaucoma gene, a hypothesis that mapping data
support (Mears et al. 1998). Although we cannot ex-
clude the involvement of a second gene, the demon-
strated duplication involving FOXC1 in a pedigree of
this size strongly suggests that alterations in gene dosage
of FOXC1 causes ocular disease, especially since du-
plications of part of FOXC1 have been shown to be
pathogenic (Kawase et al. 2000). There are no published
examples of chromosomal duplications causing either
developmental anomalies or ocular pathology in hu-
mans, although chromosomal duplications do cause
nondevelopmental conditions such as Charcot-Marie-
Tooth disease (Lupski et al. 1991) and a variety of tu-
mors (Weston et al. 1989).
The eye is known to be exquisitely sensitive to both
reduced and increased gene dosage of key developmen-
tal genes. Increased expression of PAX-6 resulting from
an increased copy number has been shown to result in
developmental ocular anomalies in transgenic mice
(Schedl et al. 1996). FOXC1 is believed to act as a
transcription factor, and it is possible that haploinsuf-
ficiency caused by FOXC1 mutations leads to altered
expression patterns of target genes. We hypothesize that
an altered pattern of gene expression arising from al-
tered FOXC1 gene dosage leads to the iris hypoplasia
phenotype. The fact that the proportion of patients who
develop glaucoma is much higher in this pedigree
(100% of individuals who can be comprehensively ex-
amined) than in other FOXC1-related phenotypes (e.g.,
∼50% in Axenfeld anomaly [Walter et al. 2000] sug-
gests that increased dosage of FOXC1 may result in a
more severe phenotype than does reduced dosage. Fur-
ther proof for this hypothesis could be obtained either
by examining the phenotype in an animal model with
an additional copy of FOXC1 or by looking for in-
creased FOXC1 expression in ocular tissue derived from
affected patients. Since most animal models require sur-
gical treatment to induce glaucoma, such a transgenic
system with early onset of the phenotype may prove to
be particularly valuable. It would also be interesting to
explore the possibility that some of the other families
with mapping to 6p25 and in which FOXC1mutations
have not been found may contain cytogenetic abnor-
malities that include the FOXC1 gene but not any ad-
jacent microsatellite markers. We are continuing this
research by investigating this duplication by using phys-
ical mapping and strand FISH.
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